Clinical importance of c-met protein expression in high grade astrocytic tumors

Yuichi Hirose, Masaru Kojima, Masachika Sagoh, Takuro Hayashi, Hideki Murakami, Kenji Shimazaki, Kazunari Yoshida, Takeshi Kawase

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The clinical importance of the expression of c-Met protein, the receptor of hepatocyte growth factor/scatter factor, was evaluated in neuroepithelial tissue tumors. c-Met immunohistochemistry was performed using the streptavidin-biotin-peroxidase complex method with anti-c-Met polyclonal antibody. Specimens were classified as c-Met negative (< 30%) or c-Met positive (≥ 30%) according to the proportion of immunopositive cells under microscopic examination. All c-Met-positive cases occurred in high grade astrocytic tumors, not in other neuroepithelial tissue tumors. Most c-Met- positive astrocytic tumors were classified histologically as high grade tumors. Epidermal growth factor-receptor (EGFR) and MIB-1 immunohistochemistry were also performed for high grade astrocytic tumors. Survival analysis was performed for patients with these tumors with variables including c-Met positivity, EGFR positivity, and MIB-1 labeling index. Positivity of c-Met was independent from EGFR positivity and MIB-1 labeling index, and the c-Met-positive group showed a significant shorter survival (p < 0.05). c-Met immunopositivity may be a parameter of biological aggressiveness in high grade astrocytic tumors. Examination of c-Met expression in astrocytic tumors provides significant clinical information, especially as a prognostic factor.

Original languageEnglish
Pages (from-to)851-859
Number of pages9
JournalNeurologia medico-chirurgica
Volume38
Issue number12
Publication statusPublished - 01-12-1998

Fingerprint

Proto-Oncogene Proteins c-met
Epidermal Growth Factor Receptor
Neoplasms
Neuroepithelial Neoplasms
Immunohistochemistry
Hepatocyte Growth Factor
Survival Analysis
Peroxidase
Survival
Antibodies

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Hirose, Y., Kojima, M., Sagoh, M., Hayashi, T., Murakami, H., Shimazaki, K., ... Kawase, T. (1998). Clinical importance of c-met protein expression in high grade astrocytic tumors. Neurologia medico-chirurgica, 38(12), 851-859.
Hirose, Yuichi ; Kojima, Masaru ; Sagoh, Masachika ; Hayashi, Takuro ; Murakami, Hideki ; Shimazaki, Kenji ; Yoshida, Kazunari ; Kawase, Takeshi. / Clinical importance of c-met protein expression in high grade astrocytic tumors. In: Neurologia medico-chirurgica. 1998 ; Vol. 38, No. 12. pp. 851-859.
@article{6d7c996f46fb4ca2a8a34f46d28d550a,
title = "Clinical importance of c-met protein expression in high grade astrocytic tumors",
abstract = "The clinical importance of the expression of c-Met protein, the receptor of hepatocyte growth factor/scatter factor, was evaluated in neuroepithelial tissue tumors. c-Met immunohistochemistry was performed using the streptavidin-biotin-peroxidase complex method with anti-c-Met polyclonal antibody. Specimens were classified as c-Met negative (< 30{\%}) or c-Met positive (≥ 30{\%}) according to the proportion of immunopositive cells under microscopic examination. All c-Met-positive cases occurred in high grade astrocytic tumors, not in other neuroepithelial tissue tumors. Most c-Met- positive astrocytic tumors were classified histologically as high grade tumors. Epidermal growth factor-receptor (EGFR) and MIB-1 immunohistochemistry were also performed for high grade astrocytic tumors. Survival analysis was performed for patients with these tumors with variables including c-Met positivity, EGFR positivity, and MIB-1 labeling index. Positivity of c-Met was independent from EGFR positivity and MIB-1 labeling index, and the c-Met-positive group showed a significant shorter survival (p < 0.05). c-Met immunopositivity may be a parameter of biological aggressiveness in high grade astrocytic tumors. Examination of c-Met expression in astrocytic tumors provides significant clinical information, especially as a prognostic factor.",
author = "Yuichi Hirose and Masaru Kojima and Masachika Sagoh and Takuro Hayashi and Hideki Murakami and Kenji Shimazaki and Kazunari Yoshida and Takeshi Kawase",
year = "1998",
month = "12",
day = "1",
language = "English",
volume = "38",
pages = "851--859",
journal = "Neurologia Medico-Chirurgica",
issn = "0387-2572",
publisher = "Japan Neurosurgical Society",
number = "12",

}

Hirose, Y, Kojima, M, Sagoh, M, Hayashi, T, Murakami, H, Shimazaki, K, Yoshida, K & Kawase, T 1998, 'Clinical importance of c-met protein expression in high grade astrocytic tumors', Neurologia medico-chirurgica, vol. 38, no. 12, pp. 851-859.

Clinical importance of c-met protein expression in high grade astrocytic tumors. / Hirose, Yuichi; Kojima, Masaru; Sagoh, Masachika; Hayashi, Takuro; Murakami, Hideki; Shimazaki, Kenji; Yoshida, Kazunari; Kawase, Takeshi.

In: Neurologia medico-chirurgica, Vol. 38, No. 12, 01.12.1998, p. 851-859.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical importance of c-met protein expression in high grade astrocytic tumors

AU - Hirose, Yuichi

AU - Kojima, Masaru

AU - Sagoh, Masachika

AU - Hayashi, Takuro

AU - Murakami, Hideki

AU - Shimazaki, Kenji

AU - Yoshida, Kazunari

AU - Kawase, Takeshi

PY - 1998/12/1

Y1 - 1998/12/1

N2 - The clinical importance of the expression of c-Met protein, the receptor of hepatocyte growth factor/scatter factor, was evaluated in neuroepithelial tissue tumors. c-Met immunohistochemistry was performed using the streptavidin-biotin-peroxidase complex method with anti-c-Met polyclonal antibody. Specimens were classified as c-Met negative (< 30%) or c-Met positive (≥ 30%) according to the proportion of immunopositive cells under microscopic examination. All c-Met-positive cases occurred in high grade astrocytic tumors, not in other neuroepithelial tissue tumors. Most c-Met- positive astrocytic tumors were classified histologically as high grade tumors. Epidermal growth factor-receptor (EGFR) and MIB-1 immunohistochemistry were also performed for high grade astrocytic tumors. Survival analysis was performed for patients with these tumors with variables including c-Met positivity, EGFR positivity, and MIB-1 labeling index. Positivity of c-Met was independent from EGFR positivity and MIB-1 labeling index, and the c-Met-positive group showed a significant shorter survival (p < 0.05). c-Met immunopositivity may be a parameter of biological aggressiveness in high grade astrocytic tumors. Examination of c-Met expression in astrocytic tumors provides significant clinical information, especially as a prognostic factor.

AB - The clinical importance of the expression of c-Met protein, the receptor of hepatocyte growth factor/scatter factor, was evaluated in neuroepithelial tissue tumors. c-Met immunohistochemistry was performed using the streptavidin-biotin-peroxidase complex method with anti-c-Met polyclonal antibody. Specimens were classified as c-Met negative (< 30%) or c-Met positive (≥ 30%) according to the proportion of immunopositive cells under microscopic examination. All c-Met-positive cases occurred in high grade astrocytic tumors, not in other neuroepithelial tissue tumors. Most c-Met- positive astrocytic tumors were classified histologically as high grade tumors. Epidermal growth factor-receptor (EGFR) and MIB-1 immunohistochemistry were also performed for high grade astrocytic tumors. Survival analysis was performed for patients with these tumors with variables including c-Met positivity, EGFR positivity, and MIB-1 labeling index. Positivity of c-Met was independent from EGFR positivity and MIB-1 labeling index, and the c-Met-positive group showed a significant shorter survival (p < 0.05). c-Met immunopositivity may be a parameter of biological aggressiveness in high grade astrocytic tumors. Examination of c-Met expression in astrocytic tumors provides significant clinical information, especially as a prognostic factor.

UR - http://www.scopus.com/inward/record.url?scp=0032418232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032418232&partnerID=8YFLogxK

M3 - Article

C2 - 10063359

AN - SCOPUS:0032418232

VL - 38

SP - 851

EP - 859

JO - Neurologia Medico-Chirurgica

JF - Neurologia Medico-Chirurgica

SN - 0387-2572

IS - 12

ER -

Hirose Y, Kojima M, Sagoh M, Hayashi T, Murakami H, Shimazaki K et al. Clinical importance of c-met protein expression in high grade astrocytic tumors. Neurologia medico-chirurgica. 1998 Dec 1;38(12):851-859.